Submission Details
| 510(k) Number | K221319 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 06, 2022 |
| Decision Date | July 21, 2023 |
| Days to Decision | 441 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
K221319 is an FDA 510(k) clearance for the BD Alaris? Pump Epidural Infusion Set, a Administrations Sets With Neuraxial Connectors (Class II — Special Controls, product code PWH), submitted by Care Fusion (San Diego, US). The FDA issued a Cleared decision on July 21, 2023, 441 days after receiving the submission on May 6, 2022. This device falls under the General Hospital review panel. Regulated under 21 CFR 880.5440.
| 510(k) Number | K221319 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 06, 2022 |
| Decision Date | July 21, 2023 |
| Days to Decision | 441 days |
| Submission Type | Traditional |
| Review Panel | General Hospital (HO) |
| Summary | Summary PDF |
| Product Code | PWH — Administrations Sets With Neuraxial Connectors |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 880.5440 |
| Definition | The Connector For Neuraxial Applications Is Intended To Facilitate Ansi/aami/iso 80369-6:2016 Compliant Neuraxial Specific Connections. |